Research output per year
Research output per year
Personal profile
Personal profile
Education
- B.Sc. in Pharmacy and Pharmaceutical Sciences, Faculty of Pharmacy, Cairo University, Egypt, 2006.
- M.Sc. in Pharmaceutical Sciences (Pharmaceutical Organic Chemistry), Faculty of Pharmacy, Cairo University, Egypt, 2011.
- Ph.D. in Chemistry (Organic Chemistry major and Biochemistry minor), Wayne State University, Detroit, MI, USA, 2017.
Research Interest
- Drug discovery, rationale design, and computer-aided drug design.
- Chemical synthesis of organic compounds with interesting biological activity, especially anti-cancer agents.
- In vitro and in cellulo biological screening of inhibitors, and molecular docking.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being -
SDG 9 Industry, Innovation, and Infrastructure
Fingerprint
Dive into the research topics where Ahmed T. Negmeldin is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Discovery of enaminone-linked benzofuran derivatives as dual VEGFR-2/hCA IX inhibitors exhibiting hypoxia-mediated chemosensitization
Eldehna, W. M., Elsayed, Z. M., Elnagar, M. R., Ammara, A., Elkotamy, M. S., Monir, R., Nocentini, A., Al-Sanea, M. M., Supuran, C. T., Tawfik, H. O., Abdel-Aziz, H. A. & Negmeldin, A. T., 1 Feb 2026, In: MedChemComm. 17, 2, p. 965-986 22 p.Research output: Contribution to journal › Article › peer-review
Open Access6 Scopus citations -
Discovery of potent bisindole-based pyrazolopyridine derivatives as topoisomerase inhibitors: DNA damage induction and synergistic antileukemic activity
Eldehna, W. M., Tawfik, H. O., Veselá, D., Peřina, M., Negmeldin, A. T., Elsayed, Z. M., Majrashi, T. A., Vojáčková, V., Elbadawi, M. M., Shaldam, M. A., Kryštof, V. & Abdel-Aziz, H. A., 2026, In: Frontiers in Pharmacology. 17, 1745220.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Isatin-triazole/imidazole hybrids as dual CDK2/VEGFR2 inhibitors with potent anti-cancer activity: design, synthesis, and biological evaluations
Elsayed, Z. M., Balaha, M., Tawfik, H. O., Khaleel, E. F., Shaldam, M. A., Negmeldin, A. T., Al-Ansary, G. H., Elimam, D. M., Omar, Y. M., di Giacomo, V. & Eldehna, W. M., 5 Jul 2026, In: Bioorganic Chemistry. 175, 109790.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Synthesis and Biological Evaluation of Imidazopyridine-Isatin Hybrids as Inhibitors of Leishmania major Growth
El Hassab, M. A., Eldehna, W. M., Elsayed, Z. M., Elbadawi, M. M., Negmeldin, A. T., Balaha, M., Nasralla, S. N., Monir, R., Ibrahim, T. M., Abe, M., Tawfik, H. O., Bekhit, A. A. & Hemeda, L. R., 2026, In: Drug Design, Development and Therapy. 20, 570670.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Correction: Formulation of zein nanoparticles for augmenting the anti-inflammatory activity of dexketoprofen (Frontiers in Pharmacology, (2025), 16, (1560585), 10.3389/fphar.2025.1560585)
El Hassab, M. A., Ibrahim, M. H., Abdel Mageed, S. S., Mahmoud, A. M. A., Othman Ahmed, Z. S., Mosallam, S., Abdelbari, M. A., Khaleel, E. F., El Hasab, M. A., Elsayyad, A., Allam, S., Eltabeeb, M. A., Negmeldin, A. T., Eldehna, W. M. & Albash, R., 2025, In: Frontiers in Pharmacology. 16, 1658349.Research output: Contribution to journal › Comment/debate
Open Access3 Scopus citations